Indeed, blocking the KRAS–HSL axis lowers lipid storage into lipid droplets, effectively reducing invasive capacity of KRAS-mutant pancreatic cancer (Rozeveld et al., 2020). Here, KRAS is linked to familial pancreatic carcinoma.